ClinicalTrials.Veeva
Menu

Find clinical trials for Kidney Disease in Cincinnati, OH

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Chronic Renal Insufficiency
Kidney Diseases
Chronic Kidney Failure
IGA Glomerulonephritis
Renal Insufficiency
Renal Cell Carcinoma
Kidney Cancer

Kidney Disease trials near Cincinnati, OH, USA:

A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis

This is a phase 3 trial of etelcalcetide in pediatric participants with secondary hyperparathyroidism (SHPT) and chronic kidney disease...

Enrolling
Chronic Kidney Disease
Secondary Hyperparathyroidism
Other: Standard of Care
Drug: Etelcalcetide

Phase 3

Amgen
Amgen

Cincinnati, Ohio, United States and 43 other locations

The purpose of this study is to assess the efficacy and safety of AZD2373 in participants diagnosed with APOL1-Mediated Kidney Disease...

Enrolling
APOL1-Mediated Kidney Disease
Combination Product: AZD2373-Arm 2
Device: APOL1 Genotyping Clinical Trial Assay

Phase 2

AstraZeneca
AstraZeneca

Cincinnati, Ohio, United States and 88 other locations

tolerability, and pharmacokinetics (PK) of VX-147 in adult and pediatric participants with apolipoprotein L1 (APOL1)-mediated proteinuric kidney...

Enrolling
Proteinuric Kidney Disease
Drug: VX-147
Drug: Placebo

Phase 2, Phase 3

Vertex Pharmaceuticals
Vertex Pharmaceuticals

Cincinnati, Ohio, United States and 330 other locations

Locations recently updated

This study is open to children aged 2 to 17 with chronic kidney disease (CKD). The purpose of this study is to find out if a medici...

Enrolling
Chronic Kidney Disease
Drug: Placebo
Drug: Empagliflozin

Phase 3

Boehringer Ingelheim
Boehringer Ingelheim

Cincinnati, Ohio, United States and 103 other locations

Recently updated

To evaluate the pharmacodynamics and safety of tolvaptan in pediatric subjects with ARPKD

Enrolling
Autosomal Recessive Polycystic Kidney (ARPKD)
Drug: Tolvaptan Tablets
Drug: Tolvaptan Suspension

Phase 3

Otsuka
Otsuka

Cincinnati, Ohio, United States and 22 other locations

and Tolerability of Baxdrostat in combination with Dapagliflozin on renal outcomes and cardiovascular mortality in participants with chronic kidney...

Enrolling
Chronic Kidney Disease and Hypertension
Drug: Baxdrostat/dapagliflozin
Drug: Placebo/dapagliflozin

Phase 3

AstraZeneca
AstraZeneca

Cincinnati, Ohio, United States and 755 other locations

Researchers are looking for a better way to treat children who have chronic kidney disease (CKD), which is long-term kidney...

Enrolling
Chronic Kidney Disease
Proteinuria
Drug: Finerenone (Kerendia, BAY94-8862)

Phase 3

Bayer
Bayer

Cincinnati, Ohio, United States and 178 other locations

Researchers are looking for a better way to treat children who have chronic kidney disease (CKD), which is long-term kidney...

Enrolling
Chronic Kidney Disease
Proteinuria
Drug: Finerenone (Kerendia, BAY94-8862)
Drug: Placebo

Phase 3

Bayer
Bayer

Cincinnati, Ohio, United States and 165 other locations

Locations recently updated

A Phase III, single-arm, multicenter pediatric clinical study evaluating atrasentan in children and adolescents aged 2 to \<18 years with primary imm...

Enrolling
Bergers Disease
Berger Disease
Drug: Drug: Atrasentan

Phase 3

Novartis
Novartis

Cincinnati, Ohio, United States and 8 other locations

renal hypoxia, and provide multifactorial kidney function support to maintain their ability to manage future stress....

Enrolling
Acute Kidney Injury
Renal Impairment
Device: Renal assist device
3ive Labs

Cincinnati, Ohio, United States and 6 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems